Open tenders for Glycanostics
8 open tenders fit what Glycanostics offers.
Tenders that fit what Glycanostics offers
Closest in meaning to its products: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal · Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for men. Tenders in other languages match too. Best fit first.
Servicii recoltare si procesare analize PSA, in cadrul proiectului "Primul proiect pilot de screening pentru cancerul de prostată din România: Mobilizare pentru Acces la screening, evaluarea Riscului, Informare și Navigare (MARIN)” Cod SMIS: 354182
Fits: Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for men
Doposażenie rezonansów magnetycznych
Fits: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal
CONTRATACION DE SERVICIO DE DETERMINACIÓN GENÓMICA TUMORAL EN PACIENTES CON TUMORES SÓLIDOS PARA LA REALIZACIÓN DEL PROYECTO DE INVESTIGACIÓN “PRECISION MEDICINE PROGRAM. STUDY PRECISO”
Fits: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal
ECHIPAMENTE MEDICALE PENTRU BIOPSIE PROSTATICĂ GHIDATĂ ROBOTIC
Fits: Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for men
Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
Fits: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal
Brachyterapiutrustning
Fits: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal
Rif. N.T. - P.A. Service sistemi diagnostici completi per l'analisi in citometria a flusso
Fits: Non-invasive prostate cancer blood test based on glycan biomarkers, measured with magnetic particles and optical signal
Biomonitorering i Riksmaten vuxna 2027-2028
Fits: Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for men